CCLD vs. DOMO, KLTR, API, XNET, GRRR, MTLS, ARQQ, RXT, GDEV, and BLZE
Should you be buying CareCloud stock or one of its competitors? The main competitors of CareCloud include Domo (DOMO), Kaltura (KLTR), Agora (API), Xunlei (XNET), Gorilla Technology Group (GRRR), Materialise (MTLS), Arqit Quantum (ARQQ), Rackspace Technology (RXT), GDEV (GDEV), and Backblaze (BLZE). These companies are all part of the "computer software" industry.
CareCloud vs.
CareCloud (NASDAQ:CCLD) and Domo (NASDAQ:DOMO) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, dividends, earnings, valuation, institutional ownership, profitability, analyst recommendations, community ranking and media sentiment.
Domo received 200 more outperform votes than CareCloud when rated by MarketBeat users. Likewise, 65.62% of users gave Domo an outperform vote while only 50.00% of users gave CareCloud an outperform vote.
In the previous week, Domo had 41 more articles in the media than CareCloud. MarketBeat recorded 42 mentions for Domo and 1 mentions for CareCloud. Domo's average media sentiment score of 0.74 beat CareCloud's score of 0.00 indicating that Domo is being referred to more favorably in the news media.
10.2% of CareCloud shares are held by institutional investors. Comparatively, 76.6% of Domo shares are held by institutional investors. 14.7% of CareCloud shares are held by company insiders. Comparatively, 14.0% of Domo shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
CareCloud has a beta of 2.05, meaning that its stock price is 105% more volatile than the S&P 500. Comparatively, Domo has a beta of 1.67, meaning that its stock price is 67% more volatile than the S&P 500.
CareCloud currently has a consensus target price of $2.50, suggesting a potential upside of 25.63%. Domo has a consensus target price of $10.67, suggesting a potential downside of 6.02%. Given CareCloud's stronger consensus rating and higher possible upside, equities research analysts clearly believe CareCloud is more favorable than Domo.
Domo has a net margin of -26.05% compared to CareCloud's net margin of -35.25%. Domo's return on equity of 0.00% beat CareCloud's return on equity.
CareCloud has higher earnings, but lower revenue than Domo. CareCloud is trading at a lower price-to-earnings ratio than Domo, indicating that it is currently the more affordable of the two stocks.
Summary
Domo beats CareCloud on 11 of the 18 factors compared between the two stocks.
Get CareCloud News Delivered to You Automatically
Sign up to receive the latest news and ratings for CCLD and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
CareCloud Competitors List
Related Companies and Tools
This page (NASDAQ:CCLD) was last updated on 5/27/2025 by MarketBeat.com Staff
Buy CCLD Stock Free CCLD Stock Alerts